Primary care of patients with serious mental illness: Your chance to make a difference

Journal of Family Practice

Volumn 57, Issue 8, 2008, Pages 515-525

  Gold, Katherine J ^a   Kilbourne, Amy M ^b,c   Valenstein, Marcia ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CITALOPRAM; LITHIUM; LITHIUM CARBONATE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SALBUTAMOL; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ADULT; AGED; AGRANULOCYTOSIS; ANTICHOLINERGIC EFFECT; ASTHMA; BIPOLAR DISORDER; BIRTH DEFECT; CASE REPORT; CATARACT; COMORBIDITY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ABUSE; DRUG METABOLISM; DRUG POTENTIATION; DYSTONIA; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HOMELESSNESS; HUMAN; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; HYPONATREMIA; KIDNEY DISEASE; LIVER DYSFUNCTION; MALE; MANIA; MENTAL DISEASE; METABOLIC SYNDROME X; MORTALITY; MYOCARDITIS; PARKINSONISM; PATIENT COMPLIANCE; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOSIS; QT PROLONGATION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SMOKING; TARDIVE DYSKINESIA; THYROID DISEASE; WEIGHT GAIN;

ADULT; AGED; COMORBIDITY; CONTINUITY OF PATIENT CARE; DRUG MONITORING; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MASS SCREENING; MENTAL DISORDERS; MIDDLE AGED; PATIENT ADVOCACY; PATIENT EDUCATION AS TOPIC; PHYSICAL EXAMINATION; PHYSICIAN'S ROLE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SUICIDE;

EID: 49449092774     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. U.S. Department of Health and Human Services. Mental Health: A Report of the Surgeon General - Executive Summary. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health; 1999.
2. Pleis JR, Lethbridge-Çejku M. Summary health statistics for U.S. adults: National Health Interview Survey 2005. National Center for Health Statistics. Vital Health Stat. 2006;10(232):1-153.
3. Peck MC, Scheffler RM. An analysis of the definitions of mental illness used in state parity laws. Psychiatr Serv. 2002;53:1089-1095.
4. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 suppl):1-50.
5. Lehman AF, Lieberman JA, Dixon LB, et al. American Psychiatric Association. Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, 2nd ed. Am J Psychiatry. 2004;161(2 suppl):1-56.
6. Ceilley JW, Cruz M, Denko T. Active medical conditions among patients on an assertive community treatment team. Community Ment Health J. 2006;42:2005-2011.
7. Hahm HC, Segal SP. Failure to seek health care among the mentally ill. Am J Orthopsychiatry. 2005;75(1):54-62.
8. Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 2004;55:1250-1257.
9. Kallert TW, Leisse M, Winiecki P. Needs for care of chronic schizophrenic patients in long-term community treatment. Soc Psychiatry Psychiatr Epidemiol. 2004;39:386-396.
10. Parks J, Svendsen D, Singer P, Foti ME, eds. Morbidity and mortality in people with serious mental illness. 13th Technical Report. Alexandria, VA: National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council; 2006.
11. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
12. McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv. 2006;57:1140-1144.
13. Chafetz L, White MC, Collins-Bride G, Nickens J, Cooper BA. Predictors of physical functioning among adults with severe mental illness. Psychiatr Serv. 2006;57:225-231.
14. Diamond RJ. What primary care physicians need to know about people with schizophrenia. WMJ. 2004;103(6):29-33.
15. Limison F, Loze JY, Philippe A, Casadebaig F, Rouillon F. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res. 2007;94:23-28.
16. Palmer BA, Pankratz S, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62:247-253.
17. Simon NM, Zalta AK, Otto MW, et al. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in out-patients with bipolar disorder. J Psychiatr Res. 2007;41:255-264.
18. Baca-Garcia E, Perez-Rodriguez MM, Sastre CD, Saiz-Ruiz J, deLeon J. Suicidal behavior in schizophrenia and depression: a comparison. Schizophr Res. 2005;75:77-81.
19. Valtonen HM, Suominen K, Mantere O, Leppämäki, Arvilommi P, Isometsä E. Suicidal behavior during different phases of bipolar disorder. J Affect Dis. 2007;97:101-107.
20. Preston E, Hansen L. A systematic review of suicide rating scales in schizophrenia. Crisis. 2005;26:170-180.
21. Lindenmayer JP, Czobor P, Alphs L, et al; for the InterSePT Study Group. The InterSePT scale for suicidal thinking reliability and validity. Schizophr Res. 2003;63:161-170.
22. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507.
23. Webb RT, Howard L, Abel KM. Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev. 2004;(2):CD004411.
24. Ernst CL, Goldberg JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry. 2002;63(suppl 4):42-55.
25. Lieberman JA, Stroup TS, McEvoy JP, et al; for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
26. Bartels SJ. Caring for the whole person: integrated health care for older adults with severe mental illness and medical comorbidity. J Am Geriatr Soc. 2004;52(12 suppl):S249-S257.
27. Holt RIG, Pevelert RC, Byrne CD. Schizophrenia, the metabolic syndrome and diabetes. Diabet Med. 2004;21:515-523.
28. Martinez-Aran A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry. 2004;161:262-270.
29. Singh MK, Giles LL, Nasrallah HA. Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract. 2006;12:90-102.
30. Cook JA. Employment barriers for persons with psychiatric disabilities: update of a report for the president's commission. Psychiatr Serv. 2006;57:1391-1405.
31. Folsom DP, Hawthorne W, Lindamer L, et al. Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. Am J Psychiatry. 2005;162:370-376.
32. Burke-Miller JK, Cook JA, Grey DD, et al. Demographic characteristics and employment among people with severe mental illness in a multisite study. Community Ment Health J. 2006;42:143-159.
33. Daumit GL, Pratt LA, Crum RM, Powe NR, Ford DE. Characteristics of primary care visits for individuals with severe mental illness in a national sample. Gen Hosp Psychiatry. 2002;24:391-395.
34. DeCoux M. Acute versus primary care: the health care decision making process for individuals with severe mental illness. Issues Ment Health Nurs. 2005;26:935-951.
35. Goldberg RW, Kreyenbuhl JA, Medoff DR, et al. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv. 2007;58:536-543.
36. Roberts L, Roalfe A, Wilson S, Lester H. Physical health care of patients with schizophrenia in primary care: a comparative study. Fam Pract. 2007;24:34-40.
37. Lester H, Tritter JQ, England E. Satisfaction with primary care: the perspectives of people with schizophrenia. Fam Pract. 2003;20:508-513.
38. Lester HE, Tritter JQ, Sorohan H. Patients' and health professionals' views on primary care for people with serious mental illness: focus group study. BMJ. 2005;330:1122.
39. Horvitz-Lennon M, Kilbourne AM, Pincus HA. From silos to bridges: meeting the general health care needs of adults with severe mental illnesses. Health Aff (Millwood). 2006;25(3):659-669.
40. Goulomb BA, Pyne JM, Jaworski BA, Wright B, Lohr JM, Bozzette SA. Primary care for patients with severe mental illness: what role can psychiatrists play? Psychiatr Serv. 2000;51:766-773.
41. Goff DC. Integrating general health care in private community psychiatry practice. J Clin Psychiatry. 2007;68(suppl 4):49-54.
42. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006;57:927-936.
43. Bauer MS, McBride L, Williford WO, et al. Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006;57:937-945.
44. Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. 2007;68(suppl 4):40-44.
45. Vreeland B. Bridging the gap between mental and physical health: a multidisciplinary approach. J Clin Psychiatry. 2007;68(suppl 4):26-33.
46. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192:421-427.
47. Carney CP, Jones L, Woolson RF. Medical comorbidity in women and men with schizophrenia. J Gen Intern Med. 2006;21:1133-1137.
48. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123:1684-1692.
49. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A, Lönnqvist J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry. 2001;58:573-578.
50. McDermott S, Moran R, Platt T, Isaac T, Wood H, Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Community Ment Health J. 2005;41:747-755.
51. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001;91:31-37.
52. Essock SM, Dowden S, Constantine NT, et al. Blood-borne infections and persons with mental illness: risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatr Serv. 2003;54:836-841.
53. Osher FC, Goldberg RW, McNary SW, et al. Blood-born infections and persons with mental illness: substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatr Serv. 2003;54:842-847.
54. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556-562.
55. Centers for Disease Control, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB prevention. Viral hepatitis C fact sheet. Last reviewed March 6, 2008. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/c/ fact.htm. Accessed July 2, 2008.
56. Centers for Disease Control, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB prevention. Viral hepatitis B fact sheet. Last modified July 26, 2007. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/b/ fact.htm. Accessed July 2, 2008.
57. Centers for Disease Control and Prevention, Department of Health and Human Services. HIV/AIDS basic statistics. Last reviewed May 22, 2008. http://www.cdc.gov/hiv/topics/surveillance/basic.htm. Accessed July 2, 2008.
58. Allison DB, Fontaine KR, Heo M, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry. 1999;60:215-220.
59. Homel P, Casey D, Allison DB. Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophr Res. 2002;55:277-284.
60. Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334-1349.
61. Kilbourne AM, Post EP, Bauer MS, et al. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. J Affect Disord. 2007;102:145-151.
62. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596-601.
63. ACOG Committee on Obstetric Practice. Treatment with selective serotonin reuptake inhibitors during pregnancy. Obstet Gynecol. 2006;108:1601-1603.